MMP9 and cancer: The latter has a wide range of functions: firstly, it acts as a chronic pro-inflammatory/pro-tumoral agent via the chemoattraction of Th17; secondly, it can be considered a disruptor of APCs helping cancer cells in immunity escape and a cancer promoter thanks to the induction of matrix metalloproteinase 9 (MMP-9) [10].